Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 4/20 | 0.41 |
| ▸ | CTSD | P07339 | 2/20 | 0.41 |
| ▸ | ECE1 | P42892 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | BMP1 | P13497 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4221433 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL27396231 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL27396227 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL8430995 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL2492939 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL6600219 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL8429139 | 0.93 | NOD1 (0.47) | NOD1BACE1ECE1KMT2AFOLH1 | |
| SCHEMBL29498236 | 0.92 | BACE1 (0.41) | NOD1BACE1CTSDECE1KMT2A | |
| SCHEMBL29370769 | 0.87 | ENPEP (0.46) | BACE1CTSDENPEPFOLH1 | |
| SCHEMBL30844356 | 0.87 | BACE1 (0.46) | NOD1BACE1ECE1KMT2AFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3252 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115038722-B | Antibodies against KLK5 | UCB biopharmaceutical Co.,Ltd. (BE) | 2026-05-26 | — | — | CN | disclosed |
| CN-108290931-B | Novel polypeptides having affinity for PD-L1 | AFFIBODY AB (SE) | 2026-05-26 | — | — | CN | disclosed |
| CN-107513103-B | MASP isoforms as inhibitors of complement activation | OMEROS CORP. (US) | 2026-05-26 | — | — | CN | disclosed |
| CN-116410307-B | Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-116194479-B | Anti-TAU antibodies | GT创新公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-106459939-B | Lipase variants and polynucleotides encoding same | 诺维信公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-117285644-B | Phase change regulating element and application thereof | 清华大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260132205-A1 | CAR FOR USE IN THE TREATMENT OF HVG DISEASE | MEDIZINISCHE HOCHSCHULE HANNOVER (DE) | 2026-05-14 | — | — | US | disclosed |
| US-12622952-B2 | Formulations comprising recombinant acid α-glucosidase | AMICUS THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| CN-113480650-B | Preparation method and application of fully human-derived targeting CD276 CAR-T cell | 徐州医科大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980925-A | Catalytic synthesis of taxol and its derivatives by using 10-deacetylbaccatin III 10 beta-O-acetyltransferase mutant | 中国医学科学院药物研究所 | 2022-01-28 | — | — | CN | disclosed |
| CN-107074948-B | Antibodies that bind AXL | 根马布股份公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113967253-A | Immunotherapy by disrupting PD-1/PD-L1 signaling | 百时美施贵宝公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-112553182-B | Alpha-galactosidase with enhanced activity | 东莞泛亚太生物科技有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-107614695-B | Methods of treating obesity and non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with glucagon receptor antagonist antibodies | 瑞美德生物医药科技有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-109563449-B | Use of enzymes, compositions and methods for removing soils | 诺维信公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-107847592-B | Antibodies against human CSF-1R for inducing lymphocytosis in lymphomas or leukemias | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957087-A | Application of Sub gene in regulation and control of cold resistance of rice | 天津市农业科学院 | 2022-01-21 | — | — | CN | disclosed |
| CN-113461818-B | CD 276-targeted fully human antibody scFv, chimeric antigen receptor, engineered immune cell and preparation method thereof | 徐州医科大学 | 2022-01-21 | — | — | CN | disclosed |